Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction

Circ J. 2005 Dec;69(12):1568-70. doi: 10.1253/circj.69.1568.

Abstract

Background: The potency and usefulness of capillary isotachophoresis (cITP) for assessing whole-serum lipoprotein profiles and quantifying electronegative low-density lipoprotein (LDL) has been previously reported.

Methods and results: A new cITP method to measure electronegative LDL in the small dense LDL fraction has been established. Both electronegative LDL and electronegative LDL in the small dense LDL fraction decreased after treatment with fenofibrate.

Conclusions: This method appears to be useful for analyzing a marker of coronary heart disease risk and may be suitable for evaluating the effects of hypolipidemic agents.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Chemical Precipitation
  • Coronary Disease / diagnosis*
  • Electrophoresis, Capillary / methods*
  • Fenofibrate / pharmacology
  • Fenofibrate / therapeutic use
  • Heparin
  • Humans
  • Hyperlipoproteinemia Type IV / blood
  • Lipoproteins, LDL / blood*
  • Risk

Substances

  • Biomarkers
  • Lipoproteins, LDL
  • Heparin
  • Fenofibrate